New subgroup analyses from the Digital Mammographic Imaging Screening Trial (DMIST) Investigators Group confirm previous results that digital screening mammography is significantly more accurate than film screening mammography in young women with dense breasts but not in women overall.
CHICAGONew subgroup analyses from the Digital Mammographic Imaging Screening Trial (DMIST) Investigators Group confirm previous results that digital screening mammography is significantly more accurate than film screening mammography in young women with dense breasts but not in women overall. Etta Pisano, MD, of the University of North Carolina School of Medicine, Chapel Hill, reported the data at the 2006 Radiological Society of North America meeting (abstract SSA15-02).
DMIST enrolled 49,528 women from 33 imaging centers in the US and Canada. All of the women had both digital and film mammography, interpreted by two readers. Findings were available for 42,760 women who underwent biopsy for a suspicious lesion or who had 1-year follow-up examination. Primary results from the study published in 2005 included 15 data analyses. The results presented at RSNA included 10 additional analyses.
The new analyses of DMIST data indicated that digital mammography was significantly better than film mammography for detecting breast cancer in one group of womenpre- or perimenopausal women with dense breast tissue (P = .0015). However, as in the original analyses, digital technology did not confer a diagnostic advantage in detecting breast cancer across-the-board. According to Dr. Pisano, subgroup analyses showed no significant difference between digital and analog mammography in breast cancer screening for any other segment of women classified by age, menopausal status, and breast density. The subgroup analyses also showed that analog mammography was slightly superior to digital technology for screening women over age 65 with fatty breasts, although the difference was not significant, she said.
Dr. Pisano believes the results favoring digital mammography in younger women with dense breasts may be due to differences in contrast. "My hypothesis is that contrast for digital mammography has been optimized for dense breasts, but not for fatty breasts," she said.
Experts Discuss Differences in Radiotherapy Outcomes in BRCA+ Breast Cancer
October 30th 2023Rebecca M. Shulman, MD, and Zachary Kiss, DO, discuss findings from a study evaluating differences in outcomes with radiotherapy and disease characteristics of patients with breast cancer harboring BRCA mutations compared with those without mutated disease.
FDA Approves Capivasertib Plus Fulvestrant in Advanced HR+, HER2– Breast Cancer
November 16th 2023Patients with locally advanced or metastatic breast cancer that is hormone receptor–positive, HER2-negative breast cancer with 1 or more PIK3CA, AKT1, or PTEN alterations may now receive capivasertib plus fulvestrant.
Oncology On-The-Go Podcast: De-escalating Breast Cancer Treatment
May 8th 2023Rakhshanda Rahman, MD, FRCS, FACS, emphasizes the importance of educating patients and physicians on the potential risks and benefits of new approaches and technologies involved in the de-escalation of breast cancer treatment.